Haoxi Health Technology (HAO) Liabilities and Shareholders Equity (2023 - 2025)

Haoxi Health Technology's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $20.7 million for Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity fell 6.37% year-over-year to $20.7 million in Q4 2025; TTM through Dec 2025 was $79.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $21.6 million, up 39.27% from the prior year.
• Liabilities and Shareholders Equity fell to $20.7 million in Q4 2025 per HAO's latest filing, from $21.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $22.1 million in Q4 2024 and bottomed at $4.5 million in Q2 2023.
• The 3-year median for Liabilities and Shareholders Equity is $20.7 million (2025), against an average of $16.9 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 247.35% in 2024 and retreated 6.37% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $4.5 million in 2023, then jumped by 394.3% to $22.1 million in 2024, then slipped by 6.37% to $20.7 million in 2025.
• Per Business Quant, the three latest HAO Liabilities and Shareholders Equity figures stand at $20.7 million (Q4 2025), $21.6 million (Q2 2025), and $22.1 million (Q4 2024).